Table 3.
Administration schedule
|
Rounds
|
Route
|
WJ-MSC
|
| Round 1 | IT | 1 × 106/kg in 3 mL |
| IV | 1 × 106/kg in 30 mL | |
| IM | 1 × 106/kg in 20 mL | |
| Round 2 (2nd week) | IT | 1 × 106/kg in 3 mL |
| IV | 1 × 106/kg in 30 mL | |
| IM | 1 × 106/kg in 20 mL | |
| Round 3 (4th week) | IT | 1 × 106/kg in 3 mL |
| IV | 1 × 106/kg in 30 mL | |
| IM | 1 × 106/kg in 20 mL | |
| Round 4 (6th week) | IT | 1 × 106/kg in 3 mL |
| IV | 1 × 106/kg in 30 mL | |
| IM | 1 × 106/kg in 20 mL |
WJ-MSC: Wharton’s jelly-derived mesenchymal stem cells; IT: Intrathecal; IV: Intravenosus; IM: Intramuscular.